Skin Analytics raised £15M in Series B funding. The company, led by Intrepid Partners, plans to use the funds for hiring, launching products, and expanding internationally.

Skin Analytics, a London, UK-based medtech company, raised £15m in Series B funding. The round was led by Intrepid Partners. The company intends to use the funds to hire new people, launch dermatology products, as well as expand internationally to new markets including Europe and Australia, and prepare for US market launch. Led by Neil Daly, founder and CEO, the company is advancing a Class IIa UKCA marked and Class III CE marked AI as a Medical Device that assesses dermoscopic images of skin lesions for skin cancer.